NANOEMULSION FORMULATION FOR TREATING DISBETES MELLITUS (DM)
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 27, 2024
app pub date -
Dec 22, 2022
filing date -
Dec 22, 2022
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The nanoemulsion (NE) formulation for treating diabetes mellitus (DM) includes pioglitazone (PGZ) and a nanoemulsion formulated with Nigella sativa oil (NSO). The (PGZ)-loaded nanoemulsion formulation can achieve a significant reduction in blood glucose levels when compared to commercially available pioglitazone formulations. Thus, it is believed that Nigella sativa oil (NSO) potentiates the hypoglycemic effect of pioglitazone (PGZ). In addition, the (PGZ)-loaded nanoemulsion formulation can be stably stored for a period of at least three months.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully